Table 2. Survival and other results of... | American Society of Hematology

Table 2.

Survival and other results of induction therapy

	DA	IA	MA	AII
CR, %
All patients, N = 348	40	43	46	42
Younger than 70 y, n = 209*	46	55	51	51
70 y or older, n = 139†	30	24	33	29
Therapy-related mortality in induction, all patients, %‡	16	22	14	17∥
Overall survival, median mo	7.7	7.5	7.2	7.5
Disease-free survival, median mo§	5.7	9.4	7.1	7

	DA	IA	MA	AII
CR, %
All patients, N = 348	40	43	46	42
Younger than 70 y, n = 209*	46	55	51	51
70 y or older, n = 139†	30	24	33	29
Therapy-related mortality in induction, all patients, %‡	16	22	14	17∥
Overall survival, median mo	7.7	7.5	7.2	7.5
Disease-free survival, median mo§	5.7	9.4	7.1	7

P = .04 for DA versus IA.

P = .37 for IA versus MA.

P = .31 for DA versus IA; P = .12 for IA versus MA.

There were 125 patients in CR; §P = .68 for DA versus IA.

By age, 13% of all patients younger than 70 years had therapy-related mortality in induction versus 22% age 70 or older; P = .04.